Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2005
12/15/2005US20050277118 Methods for identifying subjects at risk of melanoma and treatments thereof
12/15/2005US20050276819 Helicobacter pylori CAI antigen
12/15/2005US20050276811 Natural IgM antibodies and inhibitors thereof
12/15/2005US20050276802 Comprising a variable heavy (VH) domain that has non-human hypervariable region residues incorporated into a human VH domain, said variable domain comprising a framework region (FR) substitution; anticarcinogenic agents, angiogenesis inhibitors; immunoaffinity chromatography, immunoassay; containers
12/15/2005US20050276789 Immunostimulatory oligonucleotides and uses thereof
12/15/2005CA2742088A1 Antibodies that bind psca proteins for diagnosis of cancer
12/15/2005CA2569183A1 Methods and compositions for the inhibition of gene expression
12/15/2005CA2568772A1 Expression system based on recombinant vesicular stomatitis virus synthesizing t7 rna polymerase
12/15/2005CA2568642A1 Cynomolgus prostate specific antigen
12/15/2005CA2568499A1 Method of detecting cystic fibrosis associated mutations
12/15/2005CA2568405A1 Biomarkers for monitoring inhibition of impdh pathway
12/15/2005CA2567655A1 Binding moieties based on shark ignar domains
12/15/2005CA2567449A1 Antibodies and related molecules that bind to psca proteins
12/15/2005CA2567116A1 Enhancing protein expression
12/15/2005CA2567114A1 Nanoscale electronic detection system and methods for their manufacture
12/15/2005CA2567111A1 Methods and agents for screening for compounds capable of modulating vegf expression
12/14/2005EP1604996A2 An allergenic protein complex of natural rubber latex
12/14/2005EP1604172A2 Optically decodable microcarriers, arrays and methods
12/14/2005EP1604039A2 Dye compositions which provide enhanced differential fluorescence and light scatter characteristics
12/14/2005EP1604022A2 Modulation of gene expression using dna-rna hybrids
12/14/2005EP1604020A2 Method to confer cell culture replication activity to different hepatitis c virus isolates
12/14/2005EP1604013A2 Aberrantly methylated genes in pancreatic cancer
12/14/2005EP1604012A2 METHODS AND COMPOSITIONS FOR SELECTIVE RNAi MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMAL CELLS
12/14/2005EP1604009A2 Method for identifying risk of melanoma and treatments thereof
12/14/2005EP1603585A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
12/14/2005EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
12/14/2005EP1603514A2 Expression profiles for colon cancer and methods of use
12/14/2005EP1530644A4 Probes for detecting tumor cells
12/14/2005EP1442138A4 Novel germinal center kinase proteins, compositions, and methods of use
12/14/2005EP1379691A4 Differentially methylated sequences in pancreatic cancer
12/14/2005EP1366057B1 Method for deprotecting oligonucleotides
12/14/2005EP0506830B1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
12/14/2005CN1706855A Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
12/14/2005CN1231599C Gene synapsin II associated with schizophrenia and polymorphism site and use thereof
12/14/2005CN1231497C Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof
12/14/2005CN1231496C Human protein with cancer cell growth suppressing function and its coding sequence
12/14/2005CN1231492C Solution phase synthesis of oligonucleotides
12/13/2005US6974894 Genetic engineered potato starch; plant extract; adjust physical properties
12/13/2005US6974865 C3′ -methylene hydrogen phosphonate oligomers and related compounds
12/13/2005US6974703 Electro-optical devices and methods for hybridization and detection
12/13/2005US6974696 PRO853 nucleic acids
12/13/2005US6974689 Nucleic acid encoding PRO211 polypeptides
12/13/2005US6974686 Recombinant tryptophan mutants of influenza
12/13/2005US6974683 Polypeptide for use in the diagnosis and treatment of cancer
12/13/2005US6974682 Soluble interleukin-1 receptor accessory molecule
12/13/2005US6974672 Diagnosing ovavrian and colon tumors via over expression of cathepsin Z (CTSZ) and CD24 gene products; gene therapy; drug screening; antitumor agents; gene expression inhibition
12/13/2005US6974671 Determine expression level of Potentiated GlucoCorticoid induction protein, PGC-1, or mRNA; diagnose predisposition to diabetes mellitus; drug screening
12/13/2005US6974669 Bio-barcodes based on oligonucleotide-modified nanoparticles
12/13/2005US6974668 antitumor agent binds to base DNA or RNA sequence; measure cytolysis of tumor cells; drug screening
12/13/2005US6974667 Detecting the level of expression in a tissue sample of two or more genes; wherein differential expression of the genes is indicative of liver cancer
12/13/2005US6974666 bioassay preparing libraries of diverse DNA sequences and probes for use in screening studies; molecular hybridization, splicing with nucleases and removing non-complementary sections; quantitative fluorescence analysis
12/08/2005WO2005116265A2 Probe arrays for expression profiling of rat genes
12/08/2005WO2005116237A2 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination
12/08/2005WO2005116231A1 Methods for dynamic vector assembly of dna cloning vector plasmids
12/08/2005WO2005116207A1 Telomerase-inhibitory ena oligonucleotide
12/08/2005WO2005116199A2 Tobacco nicotine demethylase genomic clone and uses thereof
12/08/2005WO2005116045A1 Compositions and processes using sirna, amphipathic compounds and polycations
12/08/2005WO2005115483A1 Assay for transmissible spongiform encephalopathies
12/08/2005WO2005115480A2 Modified protein kinase a-specific oligonucleotides and methods of their use
12/08/2005WO2005100586A3 Method for construction and use of kluyveromyces lactis promoter variants in k.lactis that substantially lack e. coli transcriptional capability
12/08/2005WO2005082098A3 Polony fluorescent in situ sequencing beads
12/08/2005WO2005067410A3 Synthetic nucleic acids from aquatic species
12/08/2005WO2005060721A3 Manipulation of rna interference through modulation of armitage activity
12/08/2005WO2005047471A3 Improved fret efficiency methods
12/08/2005WO2005047469A3 PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
12/08/2005WO2005025409A3 Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms
12/08/2005WO2005019410A3 Rnai agents for anti-sars coronavirus therapy
12/08/2005WO2005018534A3 Methods and compositions for rna interference
12/08/2005WO2005014779A9 Cyclodextrin affinity purification
12/08/2005WO2005011580A3 Compositions and methods for herpes simplex prophylaxis and treatment
12/08/2005WO2004113554A3 Methods for determining susceptibility to psoriasis
12/08/2005WO2004111220A8 Proteases
12/08/2005WO2004058042A3 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
12/08/2005WO2004005468A3 Axs gene and protein and methods related thereto
12/08/2005WO2003104263A3 Cytokines and cytokine receptors with reduced immunogenicity
12/08/2005US20050273884 PUFA polyketide synthase systems and uses thereof
12/08/2005US20050273883 Pufa polyketide synthase systems and uses thereof
12/08/2005US20050273880 Polypeptides having oxaloacetate hydrolase activity and nucleic acids encoding same
12/08/2005US20050273879 Phytate polynucleotides and methods of use
12/08/2005US20050272924 Invention provides a DNA molecule capable of expressing a heterologous polypeptide under cold shock conditions, where the DNA molecule is preferably a self-replicating expression vector
12/08/2005US20050272684 Breast cancer resistance protein (BCRP) and the DNA which encodes it
12/08/2005US20050272682 SiRNA targeting PI3K signal transduction pathway and siRNA-based therapy
12/08/2005US20050272681 Ribosome structure and protein synthesis inhibitors
12/08/2005US20050272680 Oligonucleotide sequences for use in controlling diacylglycerol acyltransferase 2 a nd treatment and prevention of diabetes, liver and cardiovascular disorders; antisense agents
12/08/2005US20050272679 Contains modified ribose rings within RNA; solid phase synthesis; kits
12/08/2005US20050272678 BMP-6 estrogen responsive element and methods of use thereof
12/08/2005US20050272133 A C9-deoxomeridamycin, used as a neuroregenerative agent
12/08/2005US20050272130 Methods and compositions relating to prion-only transmission of yeast strains
12/08/2005US20050272128 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
12/08/2005US20050272127 Antibody against an angiogenesis-inhibiting peptide homologous to human ChM1L chondromodulin-I (ChM-I); hybridomas; diagnostic kits; controlling angiogenesis
12/08/2005US20050272121 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination
12/08/2005US20050272120 Compositions and methods for the diagnosis and treatment of tumor
12/08/2005US20050272099 Nucleic acids encoding androgen receptorl drug screening
12/08/2005US20050272093 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
12/08/2005US20050272092 Novel gene having reverse transcriptas motif
12/08/2005US20050272091 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection
12/08/2005US20050272089 Critical genes and polypeptides of haemophilus influenzae and methods of use
12/08/2005US20050272088 Dark quenchers for donor-acceptor energy transfer
12/08/2005US20050272086 Methods for genomic analysis
12/08/2005US20050272082 Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2)
1 ... 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 ... 899